Communicating about COVID-19 vaccine development and safety.
Alistair ThorpeAngela FagerlinJorie ButlerVanessa W StevensFrank A DrewsHolly ShoemakerMarian S RiddochLaura D SchererPublished in: PloS one (2022)
In this experimental study, we did not find that providing messages about vaccine risks and the development process had an impact on respondents' vaccine intentions. Further research is needed to identify how to effectively address concerns about the risks associated with COVID-19 vaccines and the development process and to understand additional factors that influence vaccine intentions.